After years of efforts, the Department of Ophthalmology of Xi 'an First Hospital has developed into the only modern specialized ophthalmology hospital with advanced technology level in the western region, which integrates medicine, teaching and research, and is a key discipline of the provincial (city) health department (bureau). * * * There are six wards with eight majors: keratopathy, cataract, glaucoma, eye diseases, eye trauma, eye tumors, eye muscles and integrated traditional Chinese and western medicine. Shaanxi Institute of Ophthalmology, affiliated to xi 'an First Hospital, is a provincial key laboratory, actively carrying out scientific research closely combining basic and clinical research, especially the research on corneal and ocular surface diseases, which is at an advanced and leading level in China. Over the years, * * * has won more than 20 national, provincial and municipal scientific research achievements. The institute has molecular biology, cell engineering, microbiology, clinical drug research, biochemical immune virus, dry eye and Xi 'an eye bank. Professional and technical personnel 190 people, including 49 doctoral and master students and 36 people with senior titles or above.
Xi 'an Cardiovascular Hospital has five wards, affiliated to Cardiovascular Institute. Cardiovascular Hospital has become a leading cardiovascular hospital integrating cardiology, cardiac surgery, teaching and research in China, enjoying a certain popularity in northwest China and leading in the province. The hospital has laid a material foundation for the development of cardiovascular hospital by increasing the training of internal talents and introducing outstanding talents from outside the hospital. It mainly carries out various interventional treatments of coronary heart disease, permanent pacemaker implantation, radiofrequency ablation of arrhythmia, resynchronization therapy of heart failure, coronary artery bypass grafting, interventional therapy of congenital heart disease, surgical treatment of complex congenital heart disease, balloon dilatation of rheumatic heart valve disease, valve replacement, interventional therapy and surgical treatment of peripheral vascular diseases and drug treatment of cardiovascular diseases in middle-aged and elderly people.